Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. reports a material fact notice dated October 29, 2025. The document details a corporate action approved by the Board of Directors regarding a share buyback program.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for the reporting period. The only quantitative financial data disclosed relates to capital structure:
- Outstanding Shares: 4,253,039,958 common shares (as defined in CVM Resolution 77/2022).
- Buyback Limit: Up to 208,000,000 common shares.
- Accounting Treatment: Acquisitions will be recorded as a debit on the capital reserve in the balance sheet dated September 30, 2025.
Material Changes
The primary material change is the authorization of a new share repurchase program. This represents a shift in capital allocation strategy to return value to shareholders through share cancellation or treasury stock holding.
Guidance, Outlook, and Management Commentary
Share Buyback Program Details:
- Purpose: Primary purpose is share cancellation. Uncanceled shares may be held in treasury, transferred, or used for share-based compensation plans.
- Duration: Effective until April 29, 2027.
- Execution Agents: Santander Corretora, Ágora Corretora, and Goldman Sachs do Brasil.
- Regulatory Basis: Approved pursuant to Article 30, Paragraph 1st, "b", of Law 6,404/76 and CVM Resolution 77/2022.
The filing does not contain forward-looking financial guidance, risk factors, or contingencies beyond the standard disclosure of the buyback mechanics.
Investor Verification Checklist
- Verify the total cost of the buyback program as shares are repurchased over the 18-month period.
- Monitor the ratio of shares canceled versus shares held in treasury.
- Review the impact of the capital reserve debit on the balance sheet as of September 30, 2025, and subsequent periods.
- Confirm the execution volume through the designated brokers (Santander, Ágora, Goldman Sachs).